Global Injectable Drugs For Diabetes Market Research Report 2023
Diabetes is a disease in which the level of insulin in blood increases abnormally. In type 2 diabetes, the body either doesn't produce enough insulin, or it resists insulin.
According to QYResearch’s new survey, global Injectable Drugs For Diabetes market is projected to reach US$ 49440 million in 2029, increasing from US$ 36160 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Injectable Drugs For Diabetes market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Injectable Drugs For Diabetes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Injectable Drugs For Diabetes market is projected to reach US$ 49440 million in 2029, increasing from US$ 36160 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Injectable Drugs For Diabetes market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Injectable Drugs For Diabetes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AstraZeneca
- GSK
- Merck
- Boehringer Ingelheim
- Novo Nordisk
- Sanofi
- Eli Lilly
- Insulin
- Exenatide
- Liragultide
- Pramlintide
- Others
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Drugs For Diabetes Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Insulin
1.2.3 Exenatide
1.2.4 Liragultide
1.2.5 Pramlintide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Drugs For Diabetes Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Injectable Drugs For Diabetes Market Perspective (2018-2029)
2.2 Injectable Drugs For Diabetes Growth Trends by Region
2.2.1 Global Injectable Drugs For Diabetes Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Injectable Drugs For Diabetes Historic Market Size by Region (2018-2023)
2.2.3 Injectable Drugs For Diabetes Forecasted Market Size by Region (2024-2029)
2.3 Injectable Drugs For Diabetes Market Dynamics
2.3.1 Injectable Drugs For Diabetes Industry Trends
2.3.2 Injectable Drugs For Diabetes Market Drivers
2.3.3 Injectable Drugs For Diabetes Market Challenges
2.3.4 Injectable Drugs For Diabetes Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Injectable Drugs For Diabetes Players by Revenue
3.1.1 Global Top Injectable Drugs For Diabetes Players by Revenue (2018-2023)
3.1.2 Global Injectable Drugs For Diabetes Revenue Market Share by Players (2018-2023)
3.2 Global Injectable Drugs For Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Drugs For Diabetes Revenue
3.4 Global Injectable Drugs For Diabetes Market Concentration Ratio
3.4.1 Global Injectable Drugs For Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Drugs For Diabetes Revenue in 2022
3.5 Injectable Drugs For Diabetes Key Players Head office and Area Served
3.6 Key Players Injectable Drugs For Diabetes Product Solution and Service
3.7 Date of Enter into Injectable Drugs For Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 INJECTABLE DRUGS FOR DIABETES BREAKDOWN DATA BY TYPE
4.1 Global Injectable Drugs For Diabetes Historic Market Size by Type (2018-2023)
4.2 Global Injectable Drugs For Diabetes Forecasted Market Size by Type (2024-2029)
5 INJECTABLE DRUGS FOR DIABETES BREAKDOWN DATA BY APPLICATION
5.1 Global Injectable Drugs For Diabetes Historic Market Size by Application (2018-2023)
5.2 Global Injectable Drugs For Diabetes Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Injectable Drugs For Diabetes Market Size (2018-2029)
6.2 North America Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Injectable Drugs For Diabetes Market Size by Country (2018-2023)
6.4 North America Injectable Drugs For Diabetes Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Injectable Drugs For Diabetes Market Size (2018-2029)
7.2 Europe Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Injectable Drugs For Diabetes Market Size by Country (2018-2023)
7.4 Europe Injectable Drugs For Diabetes Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Injectable Drugs For Diabetes Market Size (2018-2029)
8.2 Asia-Pacific Injectable Drugs For Diabetes Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2018-2023)
8.4 Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Injectable Drugs For Diabetes Market Size (2018-2029)
9.2 Latin America Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Injectable Drugs For Diabetes Market Size by Country (2018-2023)
9.4 Latin America Injectable Drugs For Diabetes Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Injectable Drugs For Diabetes Market Size (2018-2029)
10.2 Middle East & Africa Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2018-2023)
10.4 Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Injectable Drugs For Diabetes Introduction
11.1.4 AstraZeneca Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Injectable Drugs For Diabetes Introduction
11.2.4 GSK Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Injectable Drugs For Diabetes Introduction
11.3.4 Merck Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Injectable Drugs For Diabetes Introduction
11.4.4 Boehringer Ingelheim Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Injectable Drugs For Diabetes Introduction
11.5.4 Novo Nordisk Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.5.5 Novo Nordisk Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Injectable Drugs For Diabetes Introduction
11.6.4 Sanofi Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Detail
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Injectable Drugs For Diabetes Introduction
11.7.4 Eli Lilly Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.7.5 Eli Lilly Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Drugs For Diabetes Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Insulin
1.2.3 Exenatide
1.2.4 Liragultide
1.2.5 Pramlintide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Drugs For Diabetes Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Injectable Drugs For Diabetes Market Perspective (2018-2029)
2.2 Injectable Drugs For Diabetes Growth Trends by Region
2.2.1 Global Injectable Drugs For Diabetes Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Injectable Drugs For Diabetes Historic Market Size by Region (2018-2023)
2.2.3 Injectable Drugs For Diabetes Forecasted Market Size by Region (2024-2029)
2.3 Injectable Drugs For Diabetes Market Dynamics
2.3.1 Injectable Drugs For Diabetes Industry Trends
2.3.2 Injectable Drugs For Diabetes Market Drivers
2.3.3 Injectable Drugs For Diabetes Market Challenges
2.3.4 Injectable Drugs For Diabetes Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Injectable Drugs For Diabetes Players by Revenue
3.1.1 Global Top Injectable Drugs For Diabetes Players by Revenue (2018-2023)
3.1.2 Global Injectable Drugs For Diabetes Revenue Market Share by Players (2018-2023)
3.2 Global Injectable Drugs For Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Drugs For Diabetes Revenue
3.4 Global Injectable Drugs For Diabetes Market Concentration Ratio
3.4.1 Global Injectable Drugs For Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Drugs For Diabetes Revenue in 2022
3.5 Injectable Drugs For Diabetes Key Players Head office and Area Served
3.6 Key Players Injectable Drugs For Diabetes Product Solution and Service
3.7 Date of Enter into Injectable Drugs For Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 INJECTABLE DRUGS FOR DIABETES BREAKDOWN DATA BY TYPE
4.1 Global Injectable Drugs For Diabetes Historic Market Size by Type (2018-2023)
4.2 Global Injectable Drugs For Diabetes Forecasted Market Size by Type (2024-2029)
5 INJECTABLE DRUGS FOR DIABETES BREAKDOWN DATA BY APPLICATION
5.1 Global Injectable Drugs For Diabetes Historic Market Size by Application (2018-2023)
5.2 Global Injectable Drugs For Diabetes Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Injectable Drugs For Diabetes Market Size (2018-2029)
6.2 North America Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Injectable Drugs For Diabetes Market Size by Country (2018-2023)
6.4 North America Injectable Drugs For Diabetes Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Injectable Drugs For Diabetes Market Size (2018-2029)
7.2 Europe Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Injectable Drugs For Diabetes Market Size by Country (2018-2023)
7.4 Europe Injectable Drugs For Diabetes Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Injectable Drugs For Diabetes Market Size (2018-2029)
8.2 Asia-Pacific Injectable Drugs For Diabetes Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2018-2023)
8.4 Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Injectable Drugs For Diabetes Market Size (2018-2029)
9.2 Latin America Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Injectable Drugs For Diabetes Market Size by Country (2018-2023)
9.4 Latin America Injectable Drugs For Diabetes Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Injectable Drugs For Diabetes Market Size (2018-2029)
10.2 Middle East & Africa Injectable Drugs For Diabetes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2018-2023)
10.4 Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Injectable Drugs For Diabetes Introduction
11.1.4 AstraZeneca Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Injectable Drugs For Diabetes Introduction
11.2.4 GSK Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Injectable Drugs For Diabetes Introduction
11.3.4 Merck Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Injectable Drugs For Diabetes Introduction
11.4.4 Boehringer Ingelheim Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Injectable Drugs For Diabetes Introduction
11.5.4 Novo Nordisk Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.5.5 Novo Nordisk Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Injectable Drugs For Diabetes Introduction
11.6.4 Sanofi Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Detail
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Injectable Drugs For Diabetes Introduction
11.7.4 Eli Lilly Revenue in Injectable Drugs For Diabetes Business (2018-2023)
11.7.5 Eli Lilly Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Injectable Drugs For Diabetes Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Insulin
Table 3. Key Players of Exenatide
Table 4. Key Players of Liragultide
Table 5. Key Players of Pramlintide
Table 6. Key Players of Others
Table 7. Global Injectable Drugs For Diabetes Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Injectable Drugs For Diabetes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Injectable Drugs For Diabetes Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Injectable Drugs For Diabetes Market Share by Region (2018-2023)
Table 11. Global Injectable Drugs For Diabetes Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Injectable Drugs For Diabetes Market Share by Region (2024-2029)
Table 13. Injectable Drugs For Diabetes Market Trends
Table 14. Injectable Drugs For Diabetes Market Drivers
Table 15. Injectable Drugs For Diabetes Market Challenges
Table 16. Injectable Drugs For Diabetes Market Restraints
Table 17. Global Injectable Drugs For Diabetes Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Injectable Drugs For Diabetes Market Share by Players (2018-2023)
Table 19. Global Top Injectable Drugs For Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drugs For Diabetes as of 2022)
Table 20. Ranking of Global Top Injectable Drugs For Diabetes Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Injectable Drugs For Diabetes Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Injectable Drugs For Diabetes Product Solution and Service
Table 24. Date of Enter into Injectable Drugs For Diabetes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Drugs For Diabetes Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Injectable Drugs For Diabetes Revenue Market Share by Type (2018-2023)
Table 28. Global Injectable Drugs For Diabetes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Injectable Drugs For Diabetes Revenue Market Share by Type (2024-2029)
Table 30. Global Injectable Drugs For Diabetes Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Injectable Drugs For Diabetes Revenue Market Share by Application (2018-2023)
Table 32. Global Injectable Drugs For Diabetes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Injectable Drugs For Diabetes Revenue Market Share by Application (2024-2029)
Table 34. North America Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Injectable Drugs For Diabetes Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 49. AstraZeneca Company Detail
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Injectable Drugs For Diabetes Product
Table 52. AstraZeneca Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. GSK Company Detail
Table 55. GSK Business Overview
Table 56. GSK Injectable Drugs For Diabetes Product
Table 57. GSK Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Injectable Drugs For Diabetes Product
Table 62. Merck Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Boehringer Ingelheim Company Detail
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Injectable Drugs For Diabetes Product
Table 67. Boehringer Ingelheim Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 68. Boehringer Ingelheim Recent Development
Table 69. Novo Nordisk Company Detail
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Injectable Drugs For Diabetes Product
Table 72. Novo Nordisk Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Injectable Drugs For Diabetes Product
Table 77. Sanofi Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Eli Lilly Company Detail
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Injectable Drugs For Diabetes Product
Table 82. Eli Lilly Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
Table 1. Global Injectable Drugs For Diabetes Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Insulin
Table 3. Key Players of Exenatide
Table 4. Key Players of Liragultide
Table 5. Key Players of Pramlintide
Table 6. Key Players of Others
Table 7. Global Injectable Drugs For Diabetes Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Injectable Drugs For Diabetes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Injectable Drugs For Diabetes Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Injectable Drugs For Diabetes Market Share by Region (2018-2023)
Table 11. Global Injectable Drugs For Diabetes Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Injectable Drugs For Diabetes Market Share by Region (2024-2029)
Table 13. Injectable Drugs For Diabetes Market Trends
Table 14. Injectable Drugs For Diabetes Market Drivers
Table 15. Injectable Drugs For Diabetes Market Challenges
Table 16. Injectable Drugs For Diabetes Market Restraints
Table 17. Global Injectable Drugs For Diabetes Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Injectable Drugs For Diabetes Market Share by Players (2018-2023)
Table 19. Global Top Injectable Drugs For Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drugs For Diabetes as of 2022)
Table 20. Ranking of Global Top Injectable Drugs For Diabetes Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Injectable Drugs For Diabetes Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Injectable Drugs For Diabetes Product Solution and Service
Table 24. Date of Enter into Injectable Drugs For Diabetes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Drugs For Diabetes Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Injectable Drugs For Diabetes Revenue Market Share by Type (2018-2023)
Table 28. Global Injectable Drugs For Diabetes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Injectable Drugs For Diabetes Revenue Market Share by Type (2024-2029)
Table 30. Global Injectable Drugs For Diabetes Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Injectable Drugs For Diabetes Revenue Market Share by Application (2018-2023)
Table 32. Global Injectable Drugs For Diabetes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Injectable Drugs For Diabetes Revenue Market Share by Application (2024-2029)
Table 34. North America Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Injectable Drugs For Diabetes Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Injectable Drugs For Diabetes Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Injectable Drugs For Diabetes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Injectable Drugs For Diabetes Market Size by Country (2024-2029) & (US$ Million)
Table 49. AstraZeneca Company Detail
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Injectable Drugs For Diabetes Product
Table 52. AstraZeneca Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. GSK Company Detail
Table 55. GSK Business Overview
Table 56. GSK Injectable Drugs For Diabetes Product
Table 57. GSK Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Injectable Drugs For Diabetes Product
Table 62. Merck Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Boehringer Ingelheim Company Detail
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Injectable Drugs For Diabetes Product
Table 67. Boehringer Ingelheim Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 68. Boehringer Ingelheim Recent Development
Table 69. Novo Nordisk Company Detail
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Injectable Drugs For Diabetes Product
Table 72. Novo Nordisk Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Injectable Drugs For Diabetes Product
Table 77. Sanofi Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Eli Lilly Company Detail
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Injectable Drugs For Diabetes Product
Table 82. Eli Lilly Revenue in Injectable Drugs For Diabetes Business (2018-2023) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Injectable Drugs For Diabetes Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Injectable Drugs For Diabetes Market Share by Type: 2022 VS 2029
Figure 3. Insulin Features
Figure 4. Exenatide Features
Figure 5. Liragultide Features
Figure 6. Pramlintide Features
Figure 7. Others Features
Figure 8. Global Injectable Drugs For Diabetes Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Injectable Drugs For Diabetes Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Online Pharmacy Case Studies
Figure 13. Others Case Studies
Figure 14. Injectable Drugs For Diabetes Report Years Considered
Figure 15. Global Injectable Drugs For Diabetes Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Injectable Drugs For Diabetes Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Injectable Drugs For Diabetes Market Share by Region: 2022 VS 2029
Figure 18. Global Injectable Drugs For Diabetes Market Share by Players in 2022
Figure 19. Global Top Injectable Drugs For Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drugs For Diabetes as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Injectable Drugs For Diabetes Revenue in 2022
Figure 21. North America Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 23. United States Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 27. Germany Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Injectable Drugs For Diabetes Market Share by Region (2018-2029)
Figure 35. China Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 43. Mexico Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 47. Turkey Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 50. GSK Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 53. Novo Nordisk Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Figure 1. Global Injectable Drugs For Diabetes Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Injectable Drugs For Diabetes Market Share by Type: 2022 VS 2029
Figure 3. Insulin Features
Figure 4. Exenatide Features
Figure 5. Liragultide Features
Figure 6. Pramlintide Features
Figure 7. Others Features
Figure 8. Global Injectable Drugs For Diabetes Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Injectable Drugs For Diabetes Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Online Pharmacy Case Studies
Figure 13. Others Case Studies
Figure 14. Injectable Drugs For Diabetes Report Years Considered
Figure 15. Global Injectable Drugs For Diabetes Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Injectable Drugs For Diabetes Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Injectable Drugs For Diabetes Market Share by Region: 2022 VS 2029
Figure 18. Global Injectable Drugs For Diabetes Market Share by Players in 2022
Figure 19. Global Top Injectable Drugs For Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drugs For Diabetes as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Injectable Drugs For Diabetes Revenue in 2022
Figure 21. North America Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 23. United States Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 27. Germany Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Injectable Drugs For Diabetes Market Share by Region (2018-2029)
Figure 35. China Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 43. Mexico Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Injectable Drugs For Diabetes Market Share by Country (2018-2029)
Figure 47. Turkey Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Injectable Drugs For Diabetes Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 50. GSK Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 53. Novo Nordisk Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Injectable Drugs For Diabetes Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
